Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Abdool Karim, Salim Safurdeen.Kashuba, Angela D. M.Werner, Lise.Abdool Karim, Quarraisha.2012-11-192012-11-1920112011Abdool Karim, S.S., et al. 2011. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women Lancet, 378 (9787), pp. 279–281.0140-6736http://dx.doi.org/10.1016/S0140-6736(11)60878-7http://hdl.handle.net/10413/7897No abstract available.enAIDS (Disease) in women--Prevention.Women--Diseases--Prevention.Clinical trials.HIV infections--Prevention and control.Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.Peer reviewed journal article